GenScript is delighted to announce its 4th Annual Virtual Summit on Gene and Cell Engineering. This event will feature leading experts from academia, pharma, and biotech, showcasing the transformative ...
SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, and GenScript Biotech Corporation ...
In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
GenScript Biotech provides life science research services and products, and is well known for its gene synthesis capabilities. Its business can roughly be divided into non-cell therapy, or NCT, ...
GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...
Peptides are fundamental in life and are widely used as therapeutic agents; however, they are problematic to produce by chemical synthesis. The discovery of unusual biosynthetic pathways that produce ...
The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 /PRNewswire/ -- ...
Peptide aggregation is a long-standing challenge in chemical peptide synthesis, limiting its efficiency and reliability. Although data-driven methods have enhanced our understanding of many ...
"2025 was a year of accelerated growth and disciplined execution for GenScript," said Sherry Shao, Rotating CEO of GenScript Biotech Corporation. "We delivered strong results while continuing to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results